Paediatric Clinical Trials 2018: Exploring the complexities of paediatric drug formulation to help determine clinical endpoints
SMi is pleased to present the return of their 12th annual Paediatric Clinical Trials Conference taking place on 19th – 20th March 2018, London, UK.
Clinical trials in paediatric populations still pose several challenges and often many studies remain un- published. 10 years on from the introduction of EU Paediatric Investigation Plans (PIPs) there are still many lessons to be learned about the planning and execution of trials which should be tailored around the needs of children. Recent advancements in immuno-oncology research has led to an increase in clinical trials to treat cancer in children and adolescents. Greater emphasis has also been placed on pain-free administration of drugs in the bid to increase vaccination uptake and access to medicines.
Join industry experts to discuss current clinical trials and the innovative digital technology being used to improve clinical recruitment and retention as well as improve the quality of data being collected. Leading specialists will be looking at how to work within regulations and foster the involvement of young people in their care. The 2018 event will also focus on planning and executing a paediatric clinical trial and the ways this can vary according to region along with the complexities of paediatric drug formulation and helping attendees to determine clinical endpoints.
2018 Event Highlights will include:
– Regulatory keynote from the MHRA – The UK’s Early Access to Medicines Scheme (EAMS) and how this scheme benefits paediatric patients
– Hearing from Amgen and Roche as they give exclusive case studies on new approaches to recruitment, retention, and clinical trial design for rare diseases
– Discovering how to optimise your approach to clinical success through global collaboration being discussed by Takeda
– Pfizer and Barcelona Children’s Hospital exploring how advancements in technology are facilitating improved clinical trials and data collection for paediatric drug development
– AstraZeneca reviewing and discussing paediatric clinical trial Legislation in the EU and US
– There will be an exciting panel with the likes of GSK, Roche and regulatory bodies debating challenges and opportunities 10 years on from paediatric regulation in the EU and potential changes on the horizon
– Big pharmaceutical companies including UCB, Sanofi and GSK will debate scenarios where data extrapolation and government incentives might increase access to medicines in paediatric populations
Network and learn from leading professionals such as:
– Mark Turner, Chair European Network of Paediatric Research, Senior Lecturer in Neonatal Medicine, European Medicines Agency and University of Liverpool
– Philippe Auby, CEO & President, OEDC, Otsuka Europe
– Dominik Karres, Medical Assessor, Biologicals Unit, MHRA
– Maria Zambon, Deputy Director National Infection Service, Public Health England
– Claudio Fracasso, Global Paediatric Medical Director, Pfizer
– Trupti Dixit, Director, Strategy and Operations, Takeda
– Gerhard Zugmaier, Executive Medical Director Global Development, Amgen Research
– Meghan Thorne-Miller, Project Leader and Discovery Scientist, Rare Diseases, Roche
– Amy Cheung, Senior Clinical Pharmacometrician, Project Manager, Paediatric Working Group, AstraZeneca
Paediatric Clinical Trials 2018 will also be accompanied by an interactive post-conference workshop, running on Wednesday 21st March:
Paediatric Regulations Explained – From PIP to Reward | 08.30 – 12.30
Leader: Geneviève Michaux, Member of the Brussels and Paris Bar, Partner, Mayer Brown Europe-Brussels LLP
For more information about themust-attend meeting please visit: www.paediatric-trials.co.uk/PHARMAJOURNO
For those interested in registering, there is currently a £400 early bird discount available for all registrations made before 30stNovember2017.
For media enquiries please contact Kyra Williams on +44 20 7827 6012 or email kwilliams@smi-online.co.uk
For sponsorship opportunities or delegate bookings, contact Alia Malick on +44 (0) 20 7827 6168 or email: amalick@smi-online.co.uk
12th Annual Paediatric Clinical Trials
19th – 20th March 2018
Copthorne Tara Hotel, London, UK
www.paediatric-trials.co.uk/PHARMAJOURNO
#SMiPCT18
About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk